Literature DB >> 15477205

A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia.

Irène Dobo1, Nathalie Boiret, Eric Lippert, François Girodon, Pascal Mossuz, Magali Donnard, Lydia Campos, Danielle Pineau, Elisabeth Bascans, Vincent Praloran, Sylvie Hermouet.   

Abstract

BACKGROUND AND OBJECTIVES: The reliability of assays of endogenous megakaryocytic colony (EMC) and endogenous erythroid colony (EEC) formation for the diagnosis of thrombocytoses remains controversial. We tested the suitability of a recently developed collagen-based assay of EMC formation for the diagnosis of essential thrombocythemia (ET). DESIGN AND METHODS: This was a multicenter (8 laboratories) study including 121 patients: 82 with ET and 39 with reactive thrombocytoses (RT). EMC and EEC were assessed in each laboratory in serum-free, cytokine-free, standardized collagen gel assays; bone marrow (BM) and peripheral blood (PB) were tested in parallel.
RESULTS: In PB cultures, only EEC were specific for ET. In BM cultures, both EMC and EEC were specific for ET and present in assays of 77.8% (EMC) and 33.3% (EEC) of ET patients. Altogether, 80.2% of ET patients had BM EMC and/or EEC, whereas none of the patients with RT did. INTERPRETATION AND
CONCLUSIONS: When performed with BM progenitors for the diagnosis of thrombocytoses, positivity of the standardized EMC/EEC assay in collagen is specific (100%) and detects 80% of ET.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477205

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

1.  Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.

Authors:  Julie Mondet; Ji-Hye Park; Audrey Menard; Christophe Marzac; Serge Carillo; Emmanuel Pourcelot; Francois Girodon; Xenia Cabagnols; Laurence Lodé; Nuria Socoro; Martine Chauvet; Claude-Eric Bulabois; Pascale Cony-Makhoul; Selim Corm; Jean-Yves Cahn; Pascal Mossuz
Journal:  Haematologica       Date:  2015-02-06       Impact factor: 9.941

2.  Gene editing rescue of a novel MPL mutant associated with congenital amegakaryocytic thrombocytopenia.

Authors:  Cédric Cleyrat; Romain Girard; Eun H Choi; Éric Jeziorski; Thierry Lavabre-Bertrand; Sylvie Hermouet; Serge Carillo; Bridget S Wilson
Journal:  Blood Adv       Date:  2017-09-22

3.  Myeloproliferative Neoplasms in Children.

Authors:  Inga Hofmann
Journal:  J Hematop       Date:  2015-08-02       Impact factor: 0.196

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.